{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:15:57Z","timestamp":1791357357923,"version":"4.3.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.sleep.2013.04.010","type":"journal-article","created":{"date-parts":[[2013,8,3]],"date-time":"2013-08-03T09:00:14Z","timestamp":1375520414000},"page":"955-963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study"],"prefix":"10.1016","volume":"14","author":[{"given":"W. Joseph","family":"Herring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Hutzelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane","family":"Snavely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulette","family":"Ceesay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Michelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2013.04.010_b0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S0317167100009896","article-title":"Current evaluation and management of excessive daytime sleepiness","volume":"37","author":"Boulos","year":"2010","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.sleep.2013.04.010_b0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.smrv.2008.01.001","article-title":"From wakefulness to excessive sleepiness: what we know and still need to know","volume":"12","author":"Ohayon","year":"2008","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2013.04.010_b0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3949\/ccjm.74.8.561","article-title":"Modafinil in the treatment of excessive daytime sleepiness","volume":"74","author":"Valentino","year":"2007","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.sleep.2013.04.010_b0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1517\/13543784.17.4.565","article-title":"Armodafinil: a new treatment for excessive sleepiness","volume":"17","author":"Lankford","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.sleep.2013.04.010_b0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1146\/annurev.pa.17.040177.001545","article-title":"Histaminergic mechanisms in brain","volume":"17","author":"Schwartz","year":"1977","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"10.1016\/j.sleep.2013.04.010_b0030","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2174\/156802608784936728","article-title":"Histamine H3 antagonists as wake-promoting and pro-cognitive agents","volume":"8","author":"Stocking","year":"2008","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.sleep.2013.04.010_b0035","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.drudis.2009.02.011","article-title":"The histamine H3 receptor as a therapeutic drug target for CNS disorders","volume":"14","author":"Gemkow","year":"2009","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.sleep.2013.04.010_b0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/jpet.110.166876","article-title":"Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer\u2019s disease","volume":"336","author":"Brioni","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.sleep.2013.04.010_b0045","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","article-title":"The histamine H3 receptor: from discovery to clinical trials withpitolisant","volume":"163","author":"Schwartz","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.sleep.2013.04.010_b0050","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/clpt.2010.205","article-title":"Acute alertness-promoting effects of a novel histamine subtype-3 receptor inverse agonist in healthy sleep-deprived male volunteers","volume":"88","author":"Iannone","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.sleep.2013.04.010_b0055","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00213-010-2158-3","article-title":"Effect of a novel histamine subtype-3 receptor inverse agonist and modafinil on EEG power spectra during sleep deprivation and recovery sleep in male volunteers","volume":"215","author":"James","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.sleep.2013.04.010_b0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","article-title":"An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin\u2212\/\u2212 mice and patients","volume":"30","author":"Lin","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.sleep.2013.04.010_b0065","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1021\/jm8003834","article-title":"Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists","volume":"51","author":"Nagase","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.sleep.2013.04.010_b0070","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/0269881111398685","article-title":"The effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcohol","volume":"26","author":"Zoethout","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.sleep.2013.04.010_b0075","series-title":"International classification of sleep disorders: diagnostic and coding manual","author":"American Academy of Sleep Medicine","year":"2005"},{"key":"10.1016\/j.sleep.2013.04.010_b0080","series-title":"Clinical global impressions new clinical drug evaluation unit (ECDEU) assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.sleep.2013.04.010_b0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2013.04.010_b0090","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/sim.3684","article-title":"An adaptive design for identifying the dose with the best efficacy\/tolerability profile with application to a crossover dose-finding study","volume":"28","author":"Ivanova","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.sleep.2013.04.010_b0095","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0013-4694(82)90142-0","article-title":"Maintenance of wakefulness test: a polysomnographic technique for evaluating treatment efficacy in patients with excessive somnolence","volume":"53","author":"Mitler","year":"1982","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.sleep.2013.04.010_b0100","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1378\/chest.101.4.893","article-title":"Maintenance of wakefulness test in obstructive sleep apnea syndrome","volume":"101","author":"Poceta","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.sleep.2013.04.010_b0105","series-title":"Sleep deprivation: clinical issues, pharmacology and sleep loss effects","first-page":"39","article-title":"Psychomotor vigilance performance: neurocognitive assay sensitive to sleep loss","author":"Dorrian","year":"2005"},{"key":"10.1016\/j.sleep.2013.04.010_b0110","series-title":"WAIS-R manual","author":"Wechsler","year":"1981"},{"key":"10.1016\/j.sleep.2013.04.010_b0115","series-title":"Hayling sentence completion test","author":"Burgess","year":"1997"},{"key":"10.1016\/j.sleep.2013.04.010_b0120","series-title":"Handbook of normative data for neuropsychological assessment","first-page":"108","article-title":"Stroop test","author":"Mitrushina","year":"2005"},{"key":"10.1016\/j.sleep.2013.04.010_b0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/089198879100400406","article-title":"A new assessment tool for neuropsychopharmacologic research: the computerized neuropsychological test battery","volume":"4","author":"Veroff","year":"1991","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.sleep.2013.04.010_b0130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2174\/156720512800492530","article-title":"Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of AD","volume":"9","author":"Egan","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.sleep.2013.04.010_b0135","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.4088\/JCP.11m07178","article-title":"Randomized controlled study of the histamine inverse agonist MK-0249 in adult attention-deficit\/hyperactivity disorder","volume":"73","author":"Herring","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.sleep.2013.04.010_b0140","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/ajrccm.163.4.2005036","article-title":"Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea\/hypopnea syndrome","volume":"163","author":"Kingshott","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.sleep.2013.04.010_b0145","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.clinthera.2006.05.013","article-title":"Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea\/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults","volume":"28","author":"Roth","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.sleep.2013.04.010_b0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1389-9457(03)00108-4","article-title":"Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP","volume":"4","author":"Dinges","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2013.04.010_b0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/14656566.6.1.115","article-title":"Modafinil: new indications for wake promotion","volume":"6","author":"Schwartz","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.sleep.2013.04.010_b0160","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.sleep.2013.04.010_b0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/sleep\/28.1.123","article-title":"The clinical use of the MSLT and MWT","volume":"28","author":"Arand","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2013.04.010_b0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/sleep\/28.1.113","article-title":"Standards of practice committee of the American academy of sleep medicine. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of Wakefulness test","volume":"28","author":"Littner","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2013.04.010_b0175","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0013-4694(97)00010-2","article-title":"A normative study of the maintenance of wakefulness test (MWT)","volume":"103","author":"Doghramji","year":"1997","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.sleep.2013.04.010_b0180","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2006.06.007","article-title":"Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea\/hypopnea syndrome","volume":"101","author":"Hirshkowitz","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.sleep.2013.04.010_b0185","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/01.wnp.0000190415.83841.17","article-title":"ACNS clinical controversy: MSLT and MWT have limited clinical utility","volume":"23","author":"Bonnet","year":"2006","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.sleep.2013.04.010_b0190","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1378\/chest.08-0822","article-title":"Multiple sleep latency test and maintenance of wakefulness test","volume":"134","author":"Sullivan","year":"2008","journal-title":"Chest"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945713001500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945713001500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:09:24Z","timestamp":1761404964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945713001500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1389945713001500"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2013.04.010","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2013.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}